Clinical trial illustration

You Don't Have To Struggle With Crohn's Alone

If you're still searching for effective relief, especially if other treatments haven't fully helped, consider a potential new treatment option for Crohn's.

Access to a New Potential Treatment

Participants may receive access to innovative treatments that are not widely available.

No Cost - Ever

Study-related treatments and evaluations are provided at no cost.

Compensation For Your Time

Participants receive compensation for their time and travel expenses associated with study visits.

Expert Care Team

Our specialized team provides comprehensive care throughout the study.

Is this a good fit for me?

Step 1 of 5

Have you been diagnosed with Crohn's disease?

Hear from ourLead Doctor

Loading video...

Our PI wants to personally reach out to you so that you are aware of this study.

We would love to welcome you in and explore what options might be a good fit.

About this Study

Study Purpose

This study tests a medication that works through a completely new mechanism - blocking the TL1A protein that plays a key role in gut inflammation - potentially offering a new option for patients who haven't found relief with existing therapies.

Duration

The main part of the study lasts about one year (52 weeks). This includes a 12-week initial treatment phase followed by a 40-week maintenance phase. After that, there's an opportunity to continue in an open-label extension phase.

Location

The study is being conducted at Access Research Institute, located at 11373 Cortez Blvd Building C, Suite 200, Brooksville, FL 34613.

Share This Study

Know someone who might benefit? Share this research opportunity

TextWhatsAppMessenger

How the Investigational Treatment Works

Understanding the science behind this investigational therapy being studied for Crohn's disease

A Novel Approach to Crohn's Disease

The Science Behind RO7790121

This investigational medication represents a new approach to potentially treating Crohn's disease. By targeting TL1A, a protein that plays a central role in gut inflammation and immune response, this therapy is being studied for its potential to address both inflammation and fibrosis pathways involved in inflammatory bowel disease.

Why TL1A Matters

Research has shown that TL1A is involved in regulating gut mucosal immunity. In people with Crohn's disease, this pathway may contribute to inflammation and tissue damage. By potentially blocking TL1A, this investigational treatment is being evaluated for its ability to help manage the disease.

Monoclonal Antibody

RO7790121 is a fully human monoclonal antibody specifically designed to target TL1A

Investigational immunoglobulin G (IgG) antibody

Targets TL1A

Binds to and neutralizes tumor necrosis factor-like ligand 1A (TL1A)

TL1A is a key inflammatory protein in Crohn's disease

Blocks Inflammation

Prevents TL1A from binding to death receptor 3 (DR3)

May help reduce inflammatory pathways in the gut

Potential Benefits

Being studied to reduce gut inflammation and fibrosis

Currently under investigation in clinical trials

Dr. Luis R. Aponte

Meet your Doctor!

Dr. Salman Muddassir, MD, FACP

Dr. Salman currently serves as program director for the Internal Medicine Residency Program at Oak Hill Hospital. He received his medical degree from Quaid-e-Azam University and his pre-medical training was at Sir Syed College. He then served for 13 years at Seton Hall University Internal Medicine Program at Saint Francis Medical Center in New Jersey where he completed his internal medicine residency and was a chief resident.

Board Certified

Internal Medicine

Top Physician

Consumer Research Council of America 2010, 2011, 2014 & 2015

20+ Years

Clinical Experience

"As a doctor, I see how challenging Crohn's disease can be. This study is a way for us to explore potential options that may help people feel better and live healthier lives. Every person who joins helps us move one step closer to better care in the future."

Study Benefits

Participating in our study offers several potential advantages for patients with Crohn's disease.

Access to a New Potential Treatment

Participants may receive access to innovative treatments that are not widely available in standard clinical practice.

No Cost - Ever

Study-related treatments, evaluations, and follow-up visits are provided at no cost to eligible participants.

Compensation For Your Time

Participants receive compensation for their time and travel expenses associated with study visits.

Expert Care Team

Our specialized team of doctors, nurses, and specialists provide comprehensive care throughout the study.

How to Enroll

Ready to join our clinical study? It's simple. Just follow these easy steps.

1

Initial Consultation

Schedule your first chat with our friendly team. We'll talk about your health and see if this study is a good fit for you. We'll go over your health background, current care, and understand your condition better.

2

Screening Process

Next, we'll do a quick check-up to make sure the study is right for your specific needs. We'll walk you through everything about the study – the potential benefits and risks, what to expect, and answer all your questions.

3

Informed Consent

If you feel ready to move forward, you'll review and sign the informed consent form. This important paper explains everything: what happens in the study, the timeline, and your rights as a participant.

4

Begin Treatment

Embark on your study journey and begin your first treatment session! You'll get a personalized treatment plan made just for you, along with a clear schedule for your participation.

Frequently Asked Questions

Find answers to common questions about our clinical research study.

What is a clinical trial?

A clinical trial is a research study that evaluates new medical treatments, interventions, or devices to determine if they're safe and effective for humans. These studies follow strict scientific standards and regulatory guidelines to protect participants' safety and rights. By participating in our clinical trial, you're helping to advance medical knowledge and potentially improve future treatments for this disease.

What are the benefits of participating?

What happens after my screening call?

What does participation involve?

What is the study medication and how does it work?

Do I need insurance to participate?

Have more questions about the study?

Call Our Friendly Team

Schedule Your Free Evaluation

Find out if you're a good fit for this investigational study. Our team will contact you within 24 hours.

Doctor and patient discussing treatment options

Why Schedule Today?

Voluntary Participation

We can only accept a limited number of participants for this investigational study.

No-Cost Evaluation

Your consultation and all study-related care is provided at no cost to qualified participants.

No Obligation

The consultation is informational only - you decide if this investigational study is right for you.

Check Your Eligibility Now

Complete this quick form to see if you may qualify

Ready to learn more about this study?

Your information is secure and will never be shared with third parties

Come Visit Us

Visit our clinic location in Brooksville, FL for your consultation and study visits.

Clinic Location

Address

11373 Cortez Blvd Building C, Suite 200
Brooksville, FL 34613

Hours

Monday-Friday
9am-5pm

Accessibility

Free parking
Wheelchair accessible

Get DirectionsCall Now